Pages that link to "Q28236785"
The following pages link to The conserved box 1 motif of cytokine receptors is required for association with JAK kinases (Q28236785):
Displaying 50 items.
- CBAP interacts with the un-liganded common beta-subunit of the GM-CSF/IL-3/IL-5 receptor and induces apoptosis via mitochondrial dysfunction (Q24293174) (← links)
- An Aminopeptidase, ARTS-1, Is Required for Interleukin-6 Receptor Shedding (Q24301863) (← links)
- Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster (Q24313936) (← links)
- RANTES and MIP-1alpha activate stats in T cells (Q24316936) (← links)
- Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation (Q24319880) (← links)
- Principles of interleukin (IL)-6-type cytokine signalling and its regulation (Q24530173) (← links)
- Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway (Q24531184) (← links)
- Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation (Q24533565) (← links)
- The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor (Q24649983) (← links)
- Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain (Q24673607) (← links)
- Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor (Q24676526) (← links)
- Targeting JAK2 in the therapy of myeloproliferative neoplasms (Q26860796) (← links)
- Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity (Q28116068) (← links)
- Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction (Q28208174) (← links)
- The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor (Q28214721) (← links)
- Characterization of the signaling capacities of the novel gp130-like cytokine receptor (Q28266811) (← links)
- Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor (Q28288032) (← links)
- Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling (Q28296345) (← links)
- Separate signaling mechanisms are involved in the control of STAT protein activation and gene regulation via the interleukin 6 response element by the box 3 motif of gp130 (Q28304225) (← links)
- CRF2-4: isolation of cDNA clones encoding the human and mouse proteins (Q28304444) (← links)
- Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor (Q28565959) (← links)
- Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor (Q28590660) (← links)
- Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction (Q28609565) (← links)
- Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation (Q28637960) (← links)
- Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding (Q28646364) (← links)
- A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state (Q28646537) (← links)
- Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice (Q30433639) (← links)
- JAKs, STATs and Src kinases in hematopoiesis (Q31063082) (← links)
- Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening (Q33616659) (← links)
- Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling (Q33735931) (← links)
- Cytokines and STAT signaling (Q33784715) (← links)
- A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit (Q33864732) (← links)
- Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain (Q33890593) (← links)
- WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells (Q33895262) (← links)
- Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases (Q34012843) (← links)
- The molecular basis of growth hormone action (Q34035414) (← links)
- Janus kinases: components of multiple signaling pathways (Q34103659) (← links)
- Structural basis of recognition of interferon-α receptor by tyrosine kinase 2 (Q34165581) (← links)
- Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7–induced signaling (Q34320405) (← links)
- Signal transduction via the growth hormone receptor (Q34331449) (← links)
- Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta (Q34464999) (← links)
- Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells (Q34698039) (← links)
- Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping (Q35590849) (← links)
- Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues (Q35920777) (← links)
- Prolactin and growth hormone signaling (Q36241713) (← links)
- The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals (Q36242620) (← links)
- Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. (Q36305333) (← links)
- Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations. (Q36320552) (← links)
- His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor (Q36548417) (← links)
- A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. (Q36565214) (← links)